Showing results (431-440 of 522) with videos related to
Sort By:
Pageof 53
Lancet (London, England)|October 27, 2018
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trialDésirée van der Heijde, James Cheng-Chung Wei, Maxime Dougados, et al.The Journal of Thoracic and Cardiovascular Surgery|March 3, 2017
Causes of death from the randomized CoreValve US Pivotal High-Risk TrialVincent Gaudiani, G Michael Deeb, Jeffrey J Popma, et al.Nature Communications|April 24, 2020
The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failureAbhishek Chauhan, Lozan Sheriff, Mohammed T Hussain, et al.Journal of Clinical Psychopharmacology|July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose studyBruce J Kinon, Jan Volavka, Virginia Stauffer, et al.Clinical Epigenetics|July 8, 2015
DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosisAna Lleo, Weici Zhang, Ming Zhao, et al.BMC Surgery|April 19, 2015
The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019)Tjibbe J Gardenbroek, Thomas D Pinkney, Saloomeh Sahami, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal StudyLaura C Coates, Sreekumar G Pillai, Hasan Tahir, et al.Transplantation|March 30, 2016
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter StudyPaolo De Simone, Renato Romagnoli, Francesco Tandoi, et al.Hepatology (Baltimore, Md.)|April 20, 2018
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus InfectionNancy Reau, Paul Y Kwo, Susan Rhee, et al.Gut|July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in CaucasiansPauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.Pageof 53